ISDA: 5D7R

Deposition Date 2015-08-14

Release Date 2015-11-18

Last Version Date 2023-09-27

Entry Detail

PDB ID:

5D7R

Keywords:

ISOMERASE/ISOMERASE INHIBITOR

Title:

Crystal structure of the ATP binding domain of S. aureus GyrB complexed with a ligand

Biological Source:

Source Organism:

Staphylococcus aureus (Taxon ID: 1280)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.55 Å

R-Value Free:

0.21

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

C 1 2 1

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:DNA gyrase subunit B
Gene (Uniprot):gyrB
Chain IDs:A, B
Chain Length:212
Number of Molecules:2
Biological Source:Staphylococcus aureus

UniProt ID:P0A0K8 Pfam ID:PF02518 EC:5.6.2.2

Ligand Molecules

57Y

MPD

Primary Citation

Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors.

Zhang, J, Yang, Q, Romero, J.A, Cross, J, Wang, B, Poutsiaka, K.M, Epie, F, Bevan, D, Wu, Y, Moy, T, Daniel, A, Chamberlain, B, Carter, N, Shotwell, J, Arya, A, Kumar, V, Silverman, J, Nguyen, K, Metcalf, C.A, Ryan, D, Lippa, B, Dolle, R.E.Show

Acs Med.Chem.Lett. 6 1080 1085 (2015)

PMID: 26487916 DOI: 10.1021/acsmedchemlett.5b00266

Abstact

Antibacterials with a novel mechanism of action offer a great opportunity to combat widespread antimicrobial resistance. Bacterial DNA Gyrase is a clinically validated target. Through physiochemical property optimization of a pyrazolopyridone hit, a novel class of GyrB inhibitors were discovered. Guided by structure-based drug design, indazole derivatives with excellent enzymatic and antibacterial activity as well as great animal efficacy were discovered.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form